...
首页> 外文期刊>AIDS Research and Therapy >Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon
【24h】

Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon

机译:喀麦隆HIV阳性患者隐匿性乙型肝炎病毒感染的特征

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose Occult hepatitis B infection (OBI) among HIV positive patients varies widely in different geographic regions. We undertook a study to determine the prevalence of occult hepatitis B infection among HIV infected individuals visiting a health facility in South West Cameroon and characterized occult HBV strains based on sequence analyses. Methods Plasma samples (n?=?337), which previously tested negative for hepatitis B surface antigen (HBsAg), were screened for antibodies against hepatitis B core (anti-HBc) and surface (anti-HBs) antigens followed by DNA extraction. A 366?bp region covering the overlapping surface/polymerase gene of HBV was then amplified in a nested PCR and the amplicons sequenced using Sanger sequencing. The resulting sequences were then analyzed for genotypes and for escape and drug resistance mutations. Results Twenty samples were HBV DNA positive and were classified as OBI giving a prevalence of 5.9%. Out of these, 9 (45%) were anti-HBs positive, while 10 (52.6%) were anti-HBc positive. Additionally, 2 had dual anti-HBs and anti-HBc reactivity, while 6 had no detectable HBV antibodies. Out of the ten samples that were successfully sequenced, nine were classified as genotype E and one as genotype A. Three sequences possessed mutations associated with lamivudine resistance. We detected a number of mutations within the major hydrophilic region of the surface gene where most immune escape mutations occur. Conclusions Findings from this study show the presence of hepatitis B in patients without any of the HBV serological markers. Further prospective studies are required to determine the risk factors and markers of OBI.
机译:目的HIV阳性患者的隐匿性乙型肝炎感染(OBI)在不同地理区域之间差异很大。我们进行了一项研究,以确定在喀麦隆西南部医疗机构就诊的HIV感染者中隐匿性乙型肝炎感染的患病率,并根据序列分析确定了隐匿性HBV株的特征。方法筛选先前对乙型肝炎表面抗原(HBsAg)呈阴性的血浆样本(n?=?337),筛选抗乙型肝炎核心(anti-HBc)和表面(anti-HBs)抗原的抗体,然后进行DNA提取。然后在巢式PCR中扩增覆盖HBV重叠表面/聚合酶基因的366bp区域,并使用Sanger测序对扩增子进行测序。然后分析所得序列的基因型以及逃逸和耐药性突变。结果20份样本均为HBV DNA阳性,被归类为OBI,患病率为5.9%。其中9例(45%)为抗HBs阳性,而10例(52.6%)为抗HBc阳性。另外,有2个具有双重抗HBs和抗HBc反应性,而6个没有可检测到的HBV抗体。在成功测序的十个样本中,有九个被归为基因型E,一个被归为基因型A。三个序列具有与拉米夫定抗性相关的突变。我们在大多数免疫逃逸突变发生的表面基因的主要亲水区域内检测到许多突变。结论该研究发现表明,在没有任何HBV血清学指标的患者中存在乙型肝炎。需要进一步的前瞻性研究以确定OBI的危险因素和标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号